Related references
Note: Only part of the references are listed.First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection
M. Farouk Chughlay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
Paola Favuzza et al.
CELL HOST & MICROBE (2020)
DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis
Minsoo Song et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
The molecular basis for sugar import in malaria parasites
Abdul Aziz Qureshi et al.
NATURE (2020)
Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials
Matthew Abraham et al.
ACS INFECTIOUS DISEASES (2020)
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
Gregory M. LaMonte et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial
Aditya H. Gaur et al.
LANCET INFECTIOUS DISEASES (2020)
Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum
Xin Jiang et al.
CELL (2020)
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
Manu Vanaerschot et al.
CELL CHEMICAL BIOLOGY (2020)
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery
James M. Murithi et al.
CELL CHEMICAL BIOLOGY (2020)
The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites
Euna Yoo et al.
CELL CHEMICAL BIOLOGY (2020)
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
Beatriz Baragana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Plasmodium Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasis
Eva Istvan et al.
ELIFE (2019)
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents
Barbara H. Stokes et al.
PLOS PATHOGENS (2019)
Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target
Mahmood M. Alam et al.
SCIENCE (2019)
Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum
Joost Schalkwijk et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis
Stanley C. Xie et al.
NATURE MICROBIOLOGY (2019)
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
Jerzy M. Dziekan et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Structure-Guided Identification of Resistance Breaking Antimalarial N-Myristoyltransferase Inhibitors
Anja C. Schlott et al.
CELL CHEMICAL BIOLOGY (2019)
Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium
Marcus C. S. Lee et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2019)
Remarkable similarity in Plasmodium falciparum and Plasmodium vivax geranylgeranyl diphosphate synthase dynamics and its implication for antimalarial drug design
Aishwarya Venkatramani et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Genetic resistance to purine nucleoside phosphorylase inhibition in Plasmodium falciparum
Rodrigo G. Ducati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis
Min Zhang et al.
SCIENCE (2018)
Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics
Annie N. Cowell et al.
SCIENCE (2018)
Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery
Madeline R. Luth et al.
ACS INFECTIOUS DISEASES (2018)
A high throughput screen for next-generation leads targeting malaria parasite transmission
Michael J. Delves et al.
NATURE COMMUNICATIONS (2018)
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
Stanley C. Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials
Yevgeniya Antonova-Koch et al.
SCIENCE (2018)
Specific Inhibition of the Bifunctional Farnesyl/Geranylgeranyl Diphosphate Synthase in Malaria Parasites via a New Small-Molecule Binding Site
Jolyn E. Gisselberg et al.
CELL CHEMICAL BIOLOGY (2018)
How to tackle antimalarial resistance?
Didier Leroy
EMBO MOLECULAR MEDICINE (2017)
Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity
Gregory M. LaMonte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Plasmepsins IX and X are essential and draggable mediators of malaria parasite egress and invasion
Armiyaw S. Nasamu et al.
SCIENCE (2017)
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Tanya Paquet et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit P-falciparum Dihydroorotate Dehydrogenase
Micah Maetani et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
Ebere Sonoiki et al.
NATURE COMMUNICATIONS (2017)
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
David A. Baker et al.
NATURE COMMUNICATIONS (2017)
Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes
Ellen Bushell et al.
CELL (2017)
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
Erik L. Allman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Dynamic Structure and Inhibition of a Malaria Drug Target: Geranylgeranyl Diphosphate Synthase
Clarisse G. Ricci et al.
BIOCHEMISTRY (2016)
Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum
Alistair Miles et al.
GENOME RESEARCH (2016)
DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
Structure- and function-based design of Plasmodium-selective proteasome inhibitors
Hao Li et al.
NATURE (2016)
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
Nobutaka Kato et al.
NATURE (2016)
Dimerization of Arginyl-tRNA Synthetase by Free Heme Drives Its Inactivation in Plasmodium falciparum
Vitul Jain et al.
STRUCTURE (2016)
Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance
Gregory LaMonte et al.
MBIO (2016)
A broad analysis of resistance development in the malaria parasite
Victoria C. Corey et al.
NATURE COMMUNICATIONS (2016)
Synthetic RNA-protein modules integrated with native translation mechanisms to control gene expression in malaria parasites
Suresh M. Ganesan et al.
NATURE COMMUNICATIONS (2016)
Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes
Pamela A. Magistrado et al.
ACS INFECTIOUS DISEASES (2016)
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
Margaret A. Phillips et al.
ACS INFECTIOUS DISEASES (2016)
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Michelle Yi-Xiu Lim et al.
NATURE MICROBIOLOGY (2016)
Selective inhibition of apicoplast tryptophanyl-tRNA synthetase causes delayed death in Plasmodium falciparum
Charisse Flerida A. Pasaje et al.
SCIENTIFIC REPORTS (2016)
Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni
Shereen F. Mossallam et al.
ACTA TROPICA (2015)
Novel pantothenate derivatives for anti-malarial chemotherapy
Helmi E. Pett et al.
MALARIA JOURNAL (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
Cooperative development of antimicrobials: looking back to look ahead
Carl Nathan
NATURE REVIEWS MICROBIOLOGY (2015)
Structural basis for plasmep sin V inhibition that blocks export of malaria proteins to human erythrocytes
Anthony N. Hodder et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
Jonathan D. Herman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Structural basis for plasmep sin V inhibition that blocks export of malaria proteins to human erythrocytes
Anthony N. Hodder et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
Erika L. Flannery et al.
ACS CHEMICAL BIOLOGY (2015)
Diversity-Oriented Synthesis Probe Targets Plasmodium falciparum Cytochrome b Ubiquinone Reduction Site and Synergizes With Oxidation Site Inhibitors
Amanda K. Lukens et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
Mehdi Ghorbal et al.
NATURE BIOTECHNOLOGY (2014)
Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum
Jeffrey C. Wagner et al.
NATURE METHODS (2014)
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
Maria Belen Jimenez-Diaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains
Mark D. Preston et al.
NATURE COMMUNICATIONS (2014)
Versatile control of Plasmodium falciparum gene expression with an inducible protein-RNA interaction
Stephen J. Goldfless et al.
NATURE COMMUNICATIONS (2014)
Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design
Cho Yeow Koh et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2013)
Cloning and characterization of bifunctional enzyme farnesyl diphosphate/geranylgeranyl diphosphate synthase from Plasmodium falciparum
Fabiana M. Jordao et al.
MALARIA JOURNAL (2013)
High-level semi-synthetic production of the potent antimalarial artemisinin
C. J. Paddon et al.
NATURE (2013)
Targeting Plasmodium PI(4)K to eliminate malaria
Case W. McNamara et al.
NATURE (2013)
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
Aaron Nilsen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen Families
Selina E. R. Bopp et al.
PLOS GENETICS (2013)
Asexual Populations of the Human Malaria Parasite, Plasmodium falciparum, Use a Two-Step Genomic Strategy to Acquire Accurate, Beneficial DNA Amplifications
Jennifer L. Guler et al.
PLOS PATHOGENS (2013)
Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin
Dominic Hoepfner et al.
CELL HOST & MICROBE (2012)
Characterization of Plasmodium Liver Stage Inhibition by Halofuginone
Emily R. Derbyshire et al.
CHEMMEDCHEM (2012)
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
Tracy L. Keller et al.
NATURE CHEMICAL BIOLOGY (2012)
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor
Tae-gyu Nam et al.
ACS CHEMICAL BIOLOGY (2011)
Potent antimalarial 4-pyridones with improved physico-chemical properties
Jose M. Bueno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Identification and Validation of Tetracyclic Benzothiazepines as Plasmodium falciparum Cytochrome bc1 Inhibitors
Carolyn K. Dong et al.
CHEMISTRY & BIOLOGY (2011)
Reverse Fosmidomycin Derivatives against the Antimalarial Drug Target IspC (Dxr)
Christoph T. Behrendt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Natural products as starting points for future anti-malarial therapies: going back to our roots?
Timothy N. C. Wells
MALARIA JOURNAL (2011)
Validation of isoleucine utilization targets in Plasmodium falciparum
Eva S. Istvan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Stephan Meister et al.
SCIENCE (2011)
Optimization of Potent Inhibitors of P. falciparum Dihydroorotate Dehydrogenase for the Treatment of Malaria
Renato T. Skerlj et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses
Tarun Kumar Bhatt et al.
NATURE COMMUNICATIONS (2011)
Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model
Michael L. Booker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Structure-Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
Yuxiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Thousands of chemical starting points for antimalarial lead identification
Francisco-Javier Gamo et al.
NATURE (2010)
Chemical genetics of Plasmodium falciparum
W. Armand Guiguemde et al.
NATURE (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Design, synthesis and selection of DNA-encoded small-molecule libraries
Matthew A. Clark et al.
NATURE CHEMICAL BIOLOGY (2009)
Diversity of degradation signals in the ubiquitin-proteasome system
Tommer Ravid et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase
Richard T. Eastman et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum
RT Eastman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)